ZCA
IDXX icon

Zeke Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Zeke Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-366
Closed -$200K – 507
2022
Q1 		$200K Buy
+366
New +$193K 0.01% 486
2018
Q4 		– Sell
-1,416
Closed -$354K – 593
2018
Q3 		$354K Hold
1,416
– – 0.03% 481
2018
Q2 		$309K Hold
1,416
– – 0.03% 394
2018
Q1 		$271K Buy
+1,416
New +$261K 0.03% 468

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Zeke Capital Advisors's IDXX Position: Q2 2022 in Review

Zeke Capital Advisors sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 366 shares — an estimated $200K sold.

Zeke Capital Advisors first reported a position in IDXX in Q1 2018 and held it in 4 quarters. The position peaked at $354K in Q3 2018. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

  • Zeke Capital Advisors reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
  • Zeke Capital Advisors sold 366 Idexx Laboratories shares in Q2 2022, an estimated $200K.
  • Zeke Capital Advisors first reported a position in Idexx Laboratories in Q1 2018 and held it in 4 quarters.
  • Zeke Capital Advisors's Idexx Laboratories position peaked at $354K in Q3 2018.
  • 956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Zeke Capital Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.